Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,378 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial.
Baeten D, Baraliakos X, Braun J, Sieper J, Emery P, van der Heijde D, McInnes I, van Laar JM, Landewé R, Wordsworth P, Wollenhaupt J, Kellner H, Paramarta J, Wei J, Brachat A, Bek S, Laurent D, Li Y, Wang YA, Bertolino AP, Gsteiger S, Wright AM, Hueber W. Baeten D, et al. Among authors: emery p. Lancet. 2013 Nov 23;382(9906):1705-13. doi: 10.1016/S0140-6736(13)61134-4. Epub 2013 Sep 13. Lancet. 2013. PMID: 24035250 Clinical Trial.
Issues in rheumatoid arthritis.
Emery P, Smolen J. Emery P, et al. Lancet. 1999 Apr 3;353(9159):1186. doi: 10.1016/S0140-6736(05)74407-X. Lancet. 1999. PMID: 10210007 No abstract available.
Prescribing in the UK.
Emery P, Hawkey CJ, Moore A. Emery P, et al. Lancet. 2001 Mar 10;357(9258):809. doi: 10.1016/s0140-6736(05)71242-3. Lancet. 2001. PMID: 11254007 No abstract available.
Case definition of psoriatic arthritis.
Marzo-Ortega H, McGonagle D, Veale D, Emery P. Marzo-Ortega H, et al. Among authors: emery p. Lancet. 2000 Dec 16;356(9247):2095; author reply 2096. doi: 10.1016/S0140-6736(05)74301-4. Lancet. 2000. PMID: 11145513 No abstract available.
An anatomical explanation for good-prognosis rheumatoid arthritis.
McGonagle D, Gibbon W, O'Connor P, Green M, Pease C, Ridgway J, Emery P. McGonagle D, et al. Among authors: emery p. Lancet. 1999 Jan 9;353(9147):123-4. doi: 10.1016/S0140-6736(05)76160-2. Lancet. 1999. PMID: 10023907 No abstract available.
Classification of inflammatory arthritis.
McGonagle D, Emery P. McGonagle D, et al. Among authors: emery p. Lancet. 1999 Feb 20;353(9153):671. doi: 10.1016/S0140-6736(05)75464-7. Lancet. 1999. PMID: 10030355 No abstract available.
Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group.
Maini R, St Clair EW, Breedveld F, Furst D, Kalden J, Weisman M, Smolen J, Emery P, Harriman G, Feldmann M, Lipsky P. Maini R, et al. Among authors: emery p. Lancet. 1999 Dec 4;354(9194):1932-9. doi: 10.1016/s0140-6736(99)05246-0. Lancet. 1999. PMID: 10622295 Clinical Trial.
1,378 results